SHH and holoprosencephaly: Targeted disruption of Shh in mice and mutations in human subjects can lead to holoprosencephaly [MIM #236100], which is characterized by a variable spectrum of abnormalities in the forebrain and face (Belloni et al., 1996; Chiang et al., 1996; Roessler et al., 1996).